Ayala Pharmaceuticals (NASDAQ:ADXS) Now Covered by Analysts at StockNews.com
StockNews.com initiated coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research note issued to investors on Tuesday. The brokerage issued a sell rating on the stock. Ayala Pharmaceuticals Price Performance NASDAQ ADXS opened at $0.03 on Tuesday. Ayala Pharmaceuticals has a 52 week low of $0.00 and a 52 week high […]
